Effectiveness of intravenous infusion of N-Acetylcysteine in cirrhotic patients undergoing major abdominal surgeries

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201501001018282

Enrollment

Registered

2015-01-27

Start date

2013-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Surgery HCV

Interventions

NAcetylcysteine (NAC)

Controls

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: cirrhotic patients Child A to B scheduled for open major abdominal surgery (intestinal resection, liver resection, w hipple , hepato-biliary procedures)

Exclusion criteria

Exclusion criteria: known allergy to NAC having received NAC for contrast-induced nephropathy prevention in the previous 7 days or contrast agents in the previous 72 hrs

Design outcomes

Primary

Measure	Time frame
serum Cystatin C and Cystatin C GFR	—

Secondary

Measure	Time frame
liver function tests	—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com002-01223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026